22 related articles for article (PubMed ID: 12487831)
1. Cytokine expression profile of dengue patients at different phases of illness.
Rathakrishnan A; Wang SM; Hu Y; Khan AM; Ponnampalavanar S; Lum LC; Manikam R; Sekaran SD
PLoS One; 2012; 7(12):e52215. PubMed ID: 23284941
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages.
Buhtoiarov IN; Sondel PM; Wigginton JM; Buhtoiarova TN; Yanke EM; Mahvi DA; Rakhmilevich AL
Immunology; 2011 Feb; 132(2):226-39. PubMed ID: 21039467
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors.
Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S
Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149
[TBL] [Abstract][Full Text] [Related]
5. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
Kavgaci H; Ozdemir F; Aydin F; Yavuz A; Yavuz M
J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092
[TBL] [Abstract][Full Text] [Related]
6. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
7. Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor.
Shitara T; Ijima H; Yugami S; Sotomatu M; Kuroume T
Am J Pediatr Hematol Oncol; 1994 May; 16(2):167-72. PubMed ID: 7513137
[TBL] [Abstract][Full Text] [Related]
8. [Cytokines in cancer chemotherapy: present state and problems in use of G- and GM-CSF for solid tumors in Japan].
Ogawara M
Gan To Kagaku Ryoho; 1998 Jan; 25(2):164-70. PubMed ID: 9474924
[TBL] [Abstract][Full Text] [Related]
9. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis.
Peters BG; Adkins DR; Harrison BR; Velasquez WS; Dunphy FR; Petruska PJ; Bowers CE; Niemeyer R; McIntyre W; Vrahnos D; Auberry SE; Spitzer G
Bone Marrow Transplant; 1996 Jul; 18(1):93-102. PubMed ID: 8832001
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review.
Blayney DW; Schwartzberg L
Cancer Treat Rev; 2022 Sep; 109():102427. PubMed ID: 35785754
[No Abstract] [Full Text] [Related]
11. Endogenous pro-inflammatory cytokines in children and adolescents during chemotherapy-induced neutropenia.
Banning U; Mauz-Körholz C; Muhammad Q; Kösser A; Müller AE; Tunn U; Rieske K; Bönig H; Körholz D
Pediatr Hematol Oncol; 2002 Dec; 19(8):561-8. PubMed ID: 12487831
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]